Previous 10 | Next 10 |
Dynatronics (NASDAQ: DYNT ) +224% . More news on: Dynatronics Corporation, Altimmune, Inc., Allied Healthcare Products, Inc., Stocks on the move, , Read more ...
Among the movers: More news on: Allied Healthcare Products, Inc., iBio, Inc., Alpha Pro Tech, Ltd., Healthcare stocks news, Stocks on the move, Top Breaking stock news, Read more ...
Gainers: iBio (NYSEMKT: IBIO ) +131% . More news on: iBio, Inc., GAIN Capital Holdings, Inc., Vaxart, Inc., Stocks on the move, , Read more ...
Anaplan (NYSE: PLAN ) -29% despite Q4 beat . More news on: Anaplan, Inc., Continental Resources, Inc., Nutanix, Inc., Stocks on the move, , Read more ...
BOTHELL, WA, Feb. 27, 2020 (GLOBE NEWSWIRE) -- COCRYSTAL PHARMA, INC. ( NASDAQ: COCP ) (“Cocrystal” or the “Company”) , a clinical stage biotechnology company discovering and developing novel antiviral therapeutics, today announced that it h...
SmileDirectClub (NASDAQ: SDC ) -24% on Q4 earnings . More news on: SmileDirectClub, Inc., Spherix Incorporated, Fossil Group, Inc., Stocks on the move, , Read more ...
Penny Stocks To Watch After Coronavirus Comments This topic continues to captivate headlines: the coronavirus. A number of penny stocks have greatly benefited from speculation on “what’s next” for the virus spread. Today may have opened a bigger can of worms for investor...
Cocrystal Pharma (NASDAQ: COCP ) +63.1% pre-market after nearly tripling yesterday following news it entered into a license agreement with Kansas State University Research Foundation to further develop proprietary antiviral compounds for the treatment of norovirus and coronavirus. More...
VivoPower International PLC (NASDAQ: VVPR ) +57% on 1H results . More news on: VivoPower International PLC, Cocrystal Pharma, Inc., Mallinckrodt plc, Stocks on the move, , Read more ...
BOTHELL, WA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- - Company acquires rights to preclinical leads for Norovirus and Coronavirus therapeutics - - Proprietary platform technology will be used to further develop leads and choose clinical candidate - COCRYSTAL PHARMA, INC. (NASDAQ: C...
News, Short Squeeze, Breakout and More Instantly...
Cocrystal Pharma Inc. Company Name:
COCP Stock Symbol:
NASDAQ Market:
Cocrystal Pharma Inc. Website:
BOTHELL, Wash., July 18, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) today reported favorable safety and tolerability results from the single-ascending dose (SAD) cohorts of the Phase 1 study in healthy volunteers wit...
BOTHELL, Wash., June 20, 2024 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc .’s (Nasdaq: COCP) novel, broad-spectrum antiviral CC-42344 inhibits activity in the highly pathogenic avian influenza A (H5N1) PB2 protein recently identified in infected dairy cattle, according to recently ...
Topline single ascending dose (SAD) Phase 1 results of oral CDI-988, the first potential pan-coronavirus-pan-norovirus oral antiviral, expected in the second quarter of 2024 Enrollment completed in Phase 2a influenza A human challenge study of oral CC-42344, with topline results expected ...